Endothelial GLP-1 (Glucagon-Like Peptide-1) Receptor Mediates Cardiovascular Protection by Liraglutide In Mice With Experimental Arterial Hypertension

Cardiovascular outcome trials demonstrated that GLP-1 (glucagon-like peptide-1) analogs including liraglutide reduce the risk of cardiovascular events in type 2 diabetes mellitus. Whether GLP-1 analogs reduce the risk for atherosclerosis independent of glycemic control is challenging to elucidate as...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Arterioscler Thromb Vasc Biol
Main Authors: Helmstädter, Johanna, Frenis, Katie, Filippou, Konstantina, Grill, Alexandra, Dib, Mobin, Kalinovic, Sanela, Pawelke, Franziska, Kus, Kamil, Kröller-Schön, Swenja, Oelze, Matthias, Chlopicki, Stefan, Schuppan, Detlef, Wenzel, Philip, Ruf, Wolfram, Drucker, Daniel J., Münzel, Thomas, Daiber, Andreas, Steven, Sebastian
Format: Artigo
Jezik:Inglês
Izdano: Lippincott Williams & Wilkins 2020
Teme:
Basic Sciences
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6946108/
https://ncbi.nlm.nih.gov/pubmed/31747801
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/atv.0000615456.97862.30
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki